Synapsoft logo
AI Insights from Disclosures
Searching...
JEIL PHARMA HOLDINGS INC. 002620
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
On June 1, 2017, the company underwent a spin-off into JEIL PHARMA HOLDINGS INC., responsible for the investment business, and Jeil Pharmaceutical Co., Ltd., responsible for the pharmaceutical business. JEIL PHARMA HOLDINGS INC. is the surviving entity of the spin-off and holds all of the subsidiary and affiliate stakes previously held by Jeil Pharmaceutical Co., Ltd., the pre-spin-off company, with its main business being the resulting equity method gains, management of subsidiaries, and leasing of investment assets.
Representative Director Han Sangcheol
Founded March 7, 1959
Corporation Type KOSPI
Industry Classification Activities of head offices, management consultancy activities
Corporate number 11011-0026652
Business number 114-81-01234
Phone Number 02-549-7451
Fax Number 02-518-6485
Company Address 343 Sapyeong-daero, Seocho-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant